By Elenore Wade.
Medicare Part D’s compendium restriction on coverage of off-label drugs often prevents enrollees from receiving necessary medications. The restriction serves as a uniquely durable administrative barrier to coverage because, unlike other Medicare coverage issues, it requires patients to mount legal rather than factual challenges to coverage decisions. Agency deference to and defense of Part D plan sponsors and private drug reference entities exacerbate these issues.